Knome

About:

Knome provides human genome interpretation software and services for researchers investigating the genetic basis of rare diseases.

Website: http://www.knome.com

Twitter/X: Knome

Description:

Knome is dedicated to the functional interpretation of the human genome, rendering sequencing data into meaningful, powerful information to fuel important progress in the identification, prevention and management of disease. Founded by a globally recognized pioneer in the genomic sequencing space and an industry leader in information technology solutions, Knome is a leading expert in the interpretation of human genomes. By automating data integration and in-depth analysis, Knome's proprietary technology platform – kGAP™ 2.0 – provides the ability to derive actionable insights from the raw data of multiple genomes in record time. Knome's offerings include KnomeDISCOVERY™ for the research community and KnomeSIGHT™ for private clients and their families.

Total Funding Amount:

$28.8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2007-01-01

Contact Email:

webmaster(AT)knome.com

Founders:

George Church, Jorge Conde, Sundar Subramaniam

Number of Employees:

11-50

Last Funding Date:

2014-01-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai